Hjem › Multippel sklerose › New York › New York City
Kliniske studier for Multippel sklerose i New York City, NY
17 studier for Multippel sklerose søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of the MIND Diet for Persons With Multiple Sclerosis
Rekrutterer
- Mount Sinai Hospital, New York
Vancomycin Study in Multiple Sclerosis (MS)
RekruttererFase 1
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RekruttererObservasjonsstudie
- TG Therapeutics Investigational Trial Site, New York
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
RekruttererFase 1/2
- Mt. Sinai, New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- NYU Langone Health, New York
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
RekruttererFase 1
- TG Therapeutics Investigational Trial Site, New York
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
RekruttererFase 1
- Research Site, New York
- Research Site, New York
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
RekruttererFase 1
- Columbia University Irving Medical Center, New York
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
RekruttererFase 2
- Mount Sinai School of Medicine, New York
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
RekruttererFase 2
- NYU Langone Health, New York
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mount Sinai Hospital, New York
Genes and Environment in Multiple Sclerosis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Columbia University Irving Center, New York
A Palliative Care Model Impact on Knowledge and Attitudes
Rekrutterer
- Judith Jaffe Multiple Sclerosis Center, New York
- Hunter College, New York
NYSCF Scientific Discovery Biobank
RekruttererObservasjonsstudie
- New York Stem Cell Foundation Research Institute, New York
Eccentric Exercise and Fatigue in Multiple Sclerosis
RekruttererObservasjonsstudie
- Hunter College, Physical Therapy Department, City University of New York, New York
Effect of Cooling on Balance Performance in Multiple Sclerosis
RekruttererObservasjonsstudie
- Hunter College, Physical Therapy Department, City University of New York, New York
Multippel sklerose-studier i andre byer
- Chicago, IL15 studier
- Boston, MA14 studier
- Washington, DC13 studier
- Cleveland, OH9 studier
- San Francisco, CA8 studier
- Birmingham, AL8 studier
- St. Louis, MO8 studier
- Kansas City, KS8 studier
- Aurora, CO7 studier
- Columbus, OH7 studier
- Baltimore, MD7 studier
- Houston, TX6 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.